Imagine how it goes. You're sick enough from COVID that you're in the hospital. There's a possibility that you could die. You get asked if you want to participate in a study of a new drug. What's your decision, especially if no other COVID patient has yet received the drug? If a number of people are treated and it works well, recruitment will no doubt speed up.